Menopause Review Practice Test.

Menopause Review Practice Test. 1. Which 2 nonphar- macologic treat- ments are HIGH- LY recommended by the North Ameri- can Menopause So- ciety (NAMS) to treat VMS? 2. What other non- pharmacologic op- tions are used to treat VMS? Cognitive behavioral therapy, clinical hypnosis Temperature control (colder pillow) Yoga/relaxation therapy Avoid spicy foods, chocolate, catteine Exercise Acupuncture Paced respiration (slowed down breathing) 3. What are vasomotor Hot flushes and night sweats symptoms? 4. What are the non-VMS of menopause? 5. If patient has a uterus, you must give them 6. If patient does NOT have a uterus, you can give them 7. What are the 3 main differences in estro- Dyspareunia, vaginal dryness, mood changes, sleep disturbances, concentra- tion and memory issues, arthralgia estrogen + progestin combo estrogen alone gen of transdermal estrogens? 8. What are the 2 main differences in estro- gen of oral estro- gens? 9. What is the Women's Health Ini- tiative (WHI)? 10. What was the most important "shock- ing" result from the WHI? 11. What was the prob- lem with how the WHI ended? 12. When is it con- sidered safe to start menopause hormone therapy (MHT) in women? 13. Is tobacco use a contraindication to MHT? Lower VTE risk No impact on triglycerides Potential lower stroke risk, so lower blood clot risk Increases triglycerides Potential for decreased libido Clinical study started in 1991. Studied the use of conjugated equine estrogens (CEE) and medroxyprogesterone acetate (MPA) in women with and without a uterus Estrogen + progestin combo resulted in an increased risk of breast cancer There was some bias in the study, since it stopped early. Upon further inves- tigation 18 years later, increased mortality was not associated with hormone therapy. Women would have less side ettects over time Likely safe to start in patients with no contraindications who are within 10 years of menopause, and/or 60 years old according to NAMS (North American Menopause Society) Tobacco use is NOT a contraindication to hormone therapy, but transdermal therapy may be preferred 14. Systemic hormone therapy (HT), since it provides optimal relief of hot flushes